摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

demethoxycircumdatin H | 1129527-37-2

中文名称
——
中文别名
——
英文名称
demethoxycircumdatin H
英文别名
(S)-5b,6,7,8-tetrahydro-10H,16H-benzo[6,7]pyrrolo[2',1':3,4][1,4]diazepino[2,1-b]quinazoline -10,16-dione;(2S)-6,14,22-triazapentacyclo[12.8.0.02,6.08,13.016,21]docosa-1(22),8,10,12,16,18,20-heptaene-7,15-dione
demethoxycircumdatin H化学式
CAS
1129527-37-2
化学式
C19H15N3O2
mdl
——
分子量
317.347
InChiKey
UNFVECRPKHPNMA-INIZCTEOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    24
  • 可旋转键数:
    0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    53
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    (S)-10-(2-nitrobenzoyl)-1,2,3-trihydropyrrolo[2,1-c][1,4]benzodiazepin-5,11-dione 在 palladium 10% on activated carbon 、 氢气 作用下, 以 正己烷乙酸乙酯 为溶剂, 反应 3.0h, 生成 demethoxycircumdatin H
    参考文献:
    名称:
    通过 N-(2-硝基苯甲酰基)酰胺的还原性 N-杂环化合成喹唑啉并 [1,4] 苯二氮卓类生物碱:阿司匹林 C、环菌素 H 及其类似物的全合成
    摘要:
    据报道,利用现成的 [1,4] 苯二氮卓类与 2-硝基苯甲酰氯的偶联,可以简便且快速地合成一系列喹唑啉并 [1,4] 苯二氮卓类生物碱,包括阿斯帕林 C、环菌素 H 和一些类似物。还原性杂环化。
    DOI:
    10.3998/ark.5550190.0011.926
点击查看最新优质反应信息

文献信息

  • Silver-Mediated Oxidative Decarboxylative Intramolecular Asymmetric Radical Cyclization (C<sub>sp3</sub>–C<sub>sp2</sub>) via Memory of Chirality: Access to Circumdatin Alkaloids
    作者:Pankaj S. Mahajan、Santosh B. Mhaske
    DOI:10.1021/acs.orglett.8b00652
    日期:2018.4.6
    A novel silver-mediated oxidative decarboxylative intramolecular asymmetric radical cyclization has been developed to form a Csp3–Csp2 bond via memory of chirality. The application of the process has been demonstrated for the synthesis of the circumdatin class of alkaloids in high enantiopurity with retention of the configuration. The developed protocol is mild and works with an inexpensive silver
    已经开发了一种新型的银介导的氧化脱羧分子内不对称自由基环化反应,通过手性记忆形成了C sp3 -C sp2键。已经证明该方法的应用可合成高对映体纯度并保留构型的环丁烷类生物碱。所开发的方案是温和的,并且可以在不存在配体,碱或添加剂的情况下使用廉价的银催化剂工作。通过捕获自由基中间体已经确定了单自由基参与反应。
  • First Total Synthesis of (-)-Circumdatin H, a Novel Mitochondrial NADH Oxidase Inhibitor
    作者:D. Bose、M. Chary
    DOI:10.1055/s-0029-1218606
    日期:2010.2
    convergent synthesis of the mitochondrial NADH oxidase inhibitor (-)-circumdatin H is described. The strategy employs the intramolecular Eguchi aza-Wittig protocol as a key step to install the crucial central core BC ring system, leading to the first total synthesis of the target molecule. benzodiazepine alkaloids - circumdatin H - mitochondrial NADH oxidase - intramolecular aza-Wittig reaction - Eguchi
    线粒体NADH氧化酶抑制剂(-)-circumdatin H的高效和高度收敛的合成进行了描述。该策略采用分子内Eguchi aza-Wittig方案作为安装关键的中心核心BC环系统的关键步骤,从而实现了目标分子的首次全合成。 苯二氮卓生物碱-环丁抑菌素H-线粒体NADH氧化酶-分子内氮杂-维蒂希反应-江口协议-喹唑啉4(3 H)-ones
  • A facial synthesis of quinazolino[1,4]benzodiazepine alkaloids via reductive N-heterocyclization of N-(2-nitrobenzoyl)amides: total synthesis of asperlicin C, circumdatin H, and its analogues
    作者:Naim H. Al-Said、Khaled Q. Shawakfeh、Mohammad I. Ibrahim、Sami H. Tayyem
    DOI:10.3998/ark.5550190.0011.926
    日期:——
    A facile and short synthesis of a series of quinazolino[1,4]benzodiazepine alkaloids, including asperlicin C, circumdatin H and some analogues, is reported utilizing coupling of readily available [1,4]benzodiazepine with 2-nitrobenzoyl chlorides, followed by a reductive Nheterocyclization.
    据报道,利用现成的 [1,4] 苯二氮卓类与 2-硝基苯甲酰氯的偶联,可以简便且快速地合成一系列喹唑啉并 [1,4] 苯二氮卓类生物碱,包括阿斯帕林 C、环菌素 H 和一些类似物。还原性杂环化。
  • Total synthesis of asperlicin C, circumdatin F, demethylbenzomalvin A, demethoxycircumdatin H, sclerotigenin, and other fused quinazolinones
    作者:Ming-Chung Tseng、Huei-Yun Yang、Yen-Ho Chu
    DOI:10.1039/b910545j
    日期:——
    Using scandium triflate and microwaves, the direct double dehydrocyclization of anthranilate-containing tripeptides was achieved, affording the total syntheses of (i) quinazolino[3,2-a]benzodiazepinediones (1a–f), (ii) diazepino[2,1-b]quinazolinediones (2a–e), and (iii) pyrazino[2,1-b]quinazolinediones (3a–e) with good overall isolated yields (23–43%, 37–47% and 31–56%, respectively). Among the quinazolino[3,2-a]benzodiazepinediones synthesized, 1a (sclerotigenin), 1b (circumdatin F), and 1f (asperlicin C) are natural products.
    使用氟化铈和微波,成功实现了含有氨基苯甲酸的三肽的直接双脱氢环化,获得了以下化合物的整体合成:(i)喹唑啉[3,2-a]苯二氮杂杂环二酮(1a-f),(ii)二氮杂氟[2,1-b]喹唑啉二酮(2a-e),以及(iii)吡嗪[2,1-b]喹唑啉二酮(3a-e),它们的整体分离产率分别为23-43%,37-47%和31-56%。在合成的喹唑啉[3,2-a]苯二氮杂杂环二酮中,1a(紫锈碱)、1b(环夭碱F)和1f(曲霉素C)是天然产物。
  • Tin triflate-mediated total synthesis of circumdatin F, sclerotigenin, asperlicin C, and other quinazolino[3,2-a][1,4]benzodiazepines
    作者:Ming-Chung Tseng、Chi-Yu Lai、Yu-Wan Chu、Yen-Ho Chu
    DOI:10.1039/b813880j
    日期:——
    cyclizations of bis(anthranilate)-containing tripeptide precursors to afford the total syntheses of 7-substituted quinazolino[3,2-a][1,4]benzodiazepinediones (1a-f), including natural products circumdatin F (1a), sclerotigenin (1b), and asperlicin C (1c), were achieved with good overall isolated yields (23-62%).
    使用三氟甲磺酸锡(作为有效的路易斯酸)和微波,直接对含双(邻氨基苯甲酸酯)的三肽前体进行双环化,以提供7-取代的喹唑啉基[3,2-a] [1,4]苯并二氮杂二酮(1a -f),包括环丁抑素F(1a),硬化素(1b)和曲霉菌素C(1c)的天然产物,均具有良好的总体分离收率(23-62%)。
查看更多

同类化合物

阿斯普尼辛B 阿斯普尼辛 D 阿斯普尼辛 苯佐莫文 新骏河毒素 乙酰胺,N-(4-硝基-2-吡啶基)-,氧化(9CI) TAK960抑制剂 PLK1抑制剂(RO3280) 8H-嘧啶并[4,5-b][1,4]二氮杂卓 8-甲基-5,9-二氢-6H-嘧啶并[4,5-b][1,4]重氮基庚英-6-酮 6H-嘧啶并[4,5-b][1,4]二氮杂卓 4-甲基-6,11-二氢-3H-嘧啶并[4,5-b][1,5]苯并二氮杂卓-2,5-二酮 2-氯-7,7-二氟-5-甲基-5,7,8,9-四氢-6H-嘧啶基[4,5-B][1,4]二氮杂-6-酮 2-氯-5-甲基-5,7,8,9-四氢-6H-嘧啶[4,5-B][1,4]二氮杂6-酮 1H-嘧啶并[4,5-b][1,4]二氮杂卓 4-amino-8-(1,3-benzodioxol-5-yl)-6-phenyl-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepine 2-(2-Bromo-4-isopropyl-phenyl)-4-methyl-6-pentyl-6,7,8,9-tetrahydro-2H-2,3,5,6,9a-pentaaza-benzo[cd]azulen-1-one 2-chloro-8-(trifluoromethyl)-6H,11H-benzo[b]pyrimidino[5,4-f]-1,4-diazaperhydroepin-5-one 4,5,6,7-tetrahydro-2,4-diphenyl-4,7a,12b-triazadibenzo[e,g]azulene-1,3,8-trione 4,5,6,7-tetrahydro-4-methyl-2-phenyl-4,7a,12b-triazadibenzo[e,g]azulene-1,3,8-trione N-(4-((8,9-dimethoxy-5-methyl-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-11H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-5-methyl-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6-oxo-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-fluorophenyl)-N-(4-((8-methoxy-2-methyl-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6-oxo-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-fluorophenyl)-N-(4-((8-methoxy-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-11H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide di-tert-butyl (1r,4r)-4-(4-(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxybenzamido)cyclohexyl phosphate 2-(2-Bromo-4-isopropyl-phenyl)-6-(1-ethyl-propyl)-4-methyl-6,7,8,9-tetrahydro-2H-2,3,5,6,9a-pentaaza-benzo[cd]azulen-1-one 7,8,9,10-tetrahydro-10-hydroxy-9-heptyl-[1,4]diazepino[1,2,3-g,h]purine 7,8,9,10-tetrahydro-10-hydroxy-9-methyl-9-propyl[1,4]diazepino[1,2,3-g,h]purine 6-cyclopentyl-9-[(3-methoxyphenyl)amino]-2-methyl-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-3-one 6-cyclopentyl-9-[(2-methoxyphenyl)amino]-2-methyl-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-3-one tert-butyl 8,10-dibromo-7-oxo-1,2,5,5a,6,7-hexahydro-[1,4]diazepino[1,7-a]quinazoline-3(4H)-carboxylate tert-butyl 8,10-dimethyl-7-oxo-1,2,5,5a,6,7-hexahydro-[1,4]diazepino[1,7-a]quinazoline-3(4H)-carboxylate 11-Diallylaminoacetyl-6-isopropyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one 6-butyl-11-diallylaminoacetyl-2-phenyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one 11-chloroacetyl-6-isopropyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one 4-[(2-cyclopentyl-4,4,6-trimethyl-5-oxo-2,6,9,11-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-10-yl)amino]benzoic acid 4-[(2-cyclopentyl-6-methyl-5-oxo-2,6,9,11-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-10-yl)amino]-3-methoxy-N-(4-piperidyl)benzamide 4-[(6-cyclopentyl-2-methyl-3-oxo-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-9-yl)amino]-N-(1-ethyl-4-piperidyl)-3-methoxy-benzamide 8-(4-chlorophenyl)-6-phenyl-9H-pyrimido[4,5-b][1,4]diazepin-4-ol 1-chloro-7-methoxy-8-(3-morpholin-4-yl-propoxy)-10,11-dihydro-5H-2,4,5,11-tetraaza-dibenzo[a,d]cycloheptene 4-[(6-cyclopentyl-2-methyl-3-oxo-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-9-yl)amino]-3-methoxy-N-methyl-benzamide (S)-tert-butyl (4-chloro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-7-yl)carbamate 3-methoxy-4-[[6-(2-methoxyethyl)-2-methyl-3-oxo-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-9-yl]amino]-N-(1-methyl-4-piperidyl)benzamide (9aS,9R)-4-chloro-N-(4-methylphenyl)-9a,10,11,12-tetrahydro-9H-pyrimido[4,5-b]dipyrrolo[1,2-d:2',1'-g][1,4]diazepin-9-amine